Krito, bet perspektyvios — pelningos, fwd P/E < 50, 52 sav. augimas, diena -10%+

CORT has undergone a massive, sustained uptrend — roughly tripling from ~$40 in early April 2026 to a peak of ~$123.57 (2026-08-25) — and has spent the last ~5 weeks in a high-level consolidation/bullish flag between roughly $108 and $120. The stock sits at a decision point: the long-term trend remains powerfully bullish, but short-term momentum has stalled and is actively deteriorating at the margins.

Indicators selected (8, non-redundant): `close_200_sma`, `close_50_sma`, `close_10_ema`, `macd` (+ signal/histogram read from the verified snapshot), `rsi`, `boll` (middle, with upper/lower bands from snapshot), `atr`, `vwma`. This set spans trend (3 horizons), momentum (2), volatility/range (2), and volume-price confirmation (1) — each answering a distinct question about the current regime.

---

| Horizon | Indicator (10-01 value) | Price Relationship | Interpretation |

|---|---|---|---|

| Long-term | 200 SMA: $69.78 | Price +63% above | Secular uptrend fully intact |

| Medium-term | 50 SMA: $112.61 | Price +1.2% above | Trend intact but flattening base |

| Short-term | 10 EMA: $114.80 | Price −0.7% below | Momentum has rolled over |

• The 50 SMA has risen every single session from $84.82 (08-03) to $112.61 (10-01) — an unbroken ~$28 climb over two months. This is a strong dynamic support shelf. The 200 SMA has similarly ground higher from $62.01 to $69.78. There is no death-cross risk whatsoever; the moving-average stack remains perfectly ordered (10 EMA > 50 SMA > 200 SMA).
• Key nuance: price closed at $114.03, marginally below the 10 EMA ($114.80) for the most recent session after oscillating around it since mid-September. The 10 EMA itself has gone flat (~$114.8–115.0 for the last week), confirming short-term momentum exhaustion rather than active distribution.
• The 50 SMA at ~$112.6 and the VWMA at ~$113.1 form a confluent support zone ($112.5–113.5) that has absorbed every pullback since early September.

Verdict: Strategic trend = bullish. Tactical trend = neutral/slightly soft.

• RSI: 50.54 — dead-neutral. This is a dramatic normalization from the 72+ readings in late August (peak overbought zone 08-21 to 08-25). Importantly, during the entire September consolidation RSI has held the 45–58 band, never dipping below ~46.6 (09-18). This is classic bullish consolidation behavior — sellers have been unable to push momentum into oversold territory.
• MACD: 0.89 vs. Signal 1.09 → Histogram −0.20 — the MACD line crossed below its signal line and the histogram has gone negative. The MACD line has collapsed from a peak of 7.23 (08-25) to 0.89 — a ~88% decay. While MACD remains above zero (no trend-reversal signal), the bearish crossover warns that upside impetus has faded. Momentum traders should treat this as a yellow flag, not a sell trigger, given the zero-line support.

• ATR: 5.23 — down from 6.06 (08-03) and well off the spike highs seen around the 07-30 gap (the $92.95→$118.32 candle on 4.5M volume). Volatility is contracting as the flag forms — typical and constructive.
• Bollinger snapshot: Middle $113.99 | Upper $118.33 | Lower $109.65 — price ($114.03) sits essentially on the mid-band, with the bands relatively tight (bandwidth ≈ 7.6% of price). The market is coiling. The late-August breakdown from the upper band (~$126) to the lower region was orderly, and price has since mean-reverted to the middle — equilibrium.
• Notable: the 09-18 session printed 17.23M volume (vs. typical ~0.6–1.5M) with a wide range ($108.41–$117.90) closing at $110.29 — an institutional-scale churn day that resolved sideways rather than downward, suggesting absorption.

Support levels (evidence-based):

• $112.5–113.5 — 50 SMA ($112.61) + VWMA ($113.10) confluence; also the 09-08 and 09-23 reaction lows zone.
• $109.6–110.8 — Bollinger lower band ($109.65) + the 09-18 ($110.29) and 09-15 ($110.82) closes.
• A decisive break of ~$108 (lower band region, 09-02 low $108.73) would target the rising 50 SMA gap-fill toward $105, and potentially the $100 round number.

Resistance levels:

• $118.3 — Bollinger upper band + 09-24 high ($119.15) + 09-29 high ($120.51) zone.
• $120.4–123.6 — 09-25 high ($120.44), 08-24/08-25 double-top ($123.24/$123.57). A breakout above $123.57 on expanding volume re-opens the trend.

Trade plan:

• Existing holders (HOLD): the secular uptrend and orderly consolidation argue for patience. A trailing stop below the $108–110 zone (roughly 2× ATR under the mid-band) protects against a trend break while allowing the flag to resolve.
• New entries: momentum traders should wait for either (a) a close above ~$118.3–120.5 with MACD histogram turning positive, or (b) a pullback to the $110–112.5 shelf where RSI resets toward 40–45 with a bullish reversal candle.
• Risk: biotech headline risk is inherent; position size per ATR (5.23 ≈ 4.6% of price) — e.g., a $109 stop is ~4.4% below current price.